Fischer Medical [FISCHER] vs HSIL Limited [HSIL] Detailed Stock Comparison

Fischer Medical Ventures Ltd.

BSE
Loading...

HSIL Limited

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Fischer Medical Ventures Ltd. wins in 2 metrics, HSIL Limited wins in 9 metrics, with 0 ties. HSIL Limited appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Fischer Medical Ventures Ltd. HSIL Limited Better
P/E Ratio (TTM) 63.39 18.70 HSIL Limited
Price-to-Book Ratio 6.72 N/A N/A
Debt-to-Equity Ratio 10.26 89.90 Fischer Medical Ventures Ltd.
PEG Ratio 0.13 N/A N/A
EV/EBITDA 57.80 20.08 HSIL Limited
Profit Margin (TTM) 15.17% 72.43% HSIL Limited
Operating Margin (TTM) 20.57% N/A N/A
EBITDA Margin (TTM) 20.57% N/A N/A
Return on Equity 0.36% 1,493.74% HSIL Limited
Return on Assets (TTM) 0.26% 7.66% HSIL Limited
Free Cash Flow (TTM) $-927.26M N/A N/A
1-Year Return -57.40% -22.20% HSIL Limited
Price-to-Sales Ratio (TTM) 9.41 3.75 HSIL Limited
Enterprise Value $24.93B $64.93B HSIL Limited
EV/Revenue Ratio 9.59 4.54 HSIL Limited
Gross Profit Margin (TTM) 50.38% -49.38% Fischer Medical Ventures Ltd.
Revenue per Share (TTM) $3 N/A N/A
Earnings per Share (Diluted) $0.59 N/A N/A
Beta (Stock Volatility) -0.03 N/A N/A

Fischer Medical Ventures Ltd. vs HSIL Limited Stock Performance Analysis

Loading Price Chart...

FISCHER
HSIL

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Fischer Medical Ventures Ltd.-1.55%10.75%2.12%7.06%-21.38%-14.16%
HSIL Limited4.53%7.81%9.94%19.48%-10.96%-14.17%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Fischer Medical Ventures Ltd.-57.40%-70.45%1,348.00%-12.14%101.56%439.49%
HSIL Limited-22.20%6.42%200.14%806.19%1,225.70%2,328.54%

Performance & Financial Health Analysis: Fischer Medical Ventures Ltd. vs HSIL Limited

MetricFISCHERHSIL
Market Information
Market Cap i₹24.43B₹53.70B
Market Cap CategorySmall capMid cap
10 Day Avg. Volume i71,15857,776
90 Day Avg. Volume i126,15489,766
Last Close₹35.64₹645.75
52 Week Range₹31.13 - ₹124.20₹465.00 - ₹1,009.00
% from 52W High-71.30%-36.00%
All-Time High₹2,386.00 (Apr 21, 2008)₹1,307.90 (Dec 16, 2024)
% from All-Time High-98.51%-50.63%
Growth Metrics
Quarterly Revenue Growth7.61%-1.27%
Quarterly Earnings GrowthN/AN/A
Financial Health
Profit Margin (TTM) i0.15%0.72%
Operating Margin (TTM) i0.21%N/A
Return on Equity (TTM) i0.00%14.94%
Debt to Equity (MRQ) i10.2689.90
Cash & Liquidity
Book Value per Share (MRQ)₹5.57N/A
Cash per Share (MRQ)₹0.67N/A
Operating Cash Flow (TTM) i₹-1,015,668,000₹686.00M
Levered Free Cash Flow (TTM) i₹12.08M₹1.93B
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A₹0.00

Valuation & Enterprise Metrics Analysis: Fischer Medical Ventures Ltd. vs HSIL Limited

MetricFISCHER (Apr 24, 2026)HSIL (Jun 15, 2025)
Price Ratios
P/E Ratio (TTM) i63.3918.70
Forward P/E iN/A15.71
PEG Ratio i0.13N/A
Price to Sales (TTM) i9.413.75
Price to Book (MRQ) i6.72N/A
Market Capitalization
Market Capitalization i₹24.43B₹53.70B
Enterprise Value i₹24.93B₹64.93B
Enterprise Value Metrics
Enterprise to Revenue i9.594.54
Enterprise to EBITDA i57.8020.08
Risk & Other Metrics
Beta i-0.03N/A
Book Value per Share (MRQ) i₹5.57N/A

Financial Statements Comparison: Fischer Medical Ventures Ltd. vs HSIL Limited

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricFISCHER (2025)HSIL
Revenue/Sales i1.11BN/A
Cost of Goods Sold i915.90MN/A
COGS % of Revenue i82.7%-
Gross Profit i191.09MN/A
Gross Margin i17.3%-
Research & Development iN/AN/A
Operating Income (EBIT) i30.61MN/A
Operating Margin i2.8%-
EBITDA i53.47MN/A
EBITDA Margin i4.8%-
Pre-Tax Income i22.23MN/A
Pre-Tax Income % of Revenue i2.0%-
Income Tax i10.15MN/A
Income Tax % of Revenue i0.9%-
Net Income (Profit) i12.08MN/A
Profit Margin i1.1%-

Balance Sheet & Liquidity Metrics

MetricFISCHER (2025)HSIL
Cash & Equivalents i1.04BN/A
Total Current Assets i3.65BN/A
Total Current Assets % of Revenue i330.0%-
Total Current Liabilities i1.02BN/A
Total Current Liabilities % of Revenue i92.0%-
Long-Term Debt i172.06MN/A
Long-Term Debt % of Revenue i15.5%-
Total Shareholders Equity i3.38BN/A
Retained Earnings i29.05MN/A
Retained Earnings % of Revenue i2.6%-
Property, Plant & Equipment i89.03MN/A

Cash Flow Statement Comparison

MetricFISCHER (2025)HSIL
Operating Cash Flow i-1.02BN/A
Operating Cash Flow % of Revenue i-91.8%-
Capital Expenditures i-59.87MN/A
Free Cash Flow i-927.26MN/A
FCF Margin i-83.8%-
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricFISCHERHSIL
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i654.52M64.70M
Float Shares i164.93MN/A
% Held by Insiders i76.28%N/A
% Held by Institutions i2.54%N/A
% Held by Public i21.18%N/A

Dividend Analysis & Yield Comparison: Fischer Medical Ventures Ltd. vs HSIL Limited

MetricFISCHERHSIL
Last 12-Month Dividend iN/A₹0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A₹0.00
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/A₹0.00
Ex-Dividend DateN/AN/A